Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Usutu Virus Infections Found among Austrian Blood Donors

By LabMedica International staff writers
Posted on 24 Oct 2017
Usutu virus (USUV) is an African mosquito-borne flavivirus belonging to the Japanese encephalitis virus serocomplex. More...
USUV is closely related to Murray Valley encephalitis virus, Japanese encephalitis virus, and West Nile virus (WNV).

Besides wild birds, humans can also be infected with Usutu virus through mosquito bites. Usually human Usutu virus infections are asymptomatic though occasionally they may result in fever and rash. Neurologic symptoms and severe courses of the disease are rare in humans, although critical illness was reported in immunosuppressed patients.

European scientists led by those at the University of Veterinary Medicine (Vienna, Austria) collected samples of all blood donations collected from June 1, 2017 onwards by the Blood Service for Austrian Red Cross during the ongoing WNV transmission season 2017 and were sent to the German Red Cross, Blood Service for Baden-Württemberg-Hessen. In Germany they were screened in minipools of 19 samples using the automated nucleic acid (NAT) test on the cobas 8800 system.

The investigators reported that as of October 11, 2017, a total of seven of 12,047 blood donations collected between July 24 and August 25, 2017, reacted positive. WNV NAT-screening positive samples were retested by WNV- and Usutu virus (USUV)-specific reverse transcription (RT) - and quantitative reverse transcription polymerase chain (RT-qPCR) assays as well as by conventional RT-PCR tests amplifying a wide range of flaviviruses. While one blood donation was confirmed as containing WNV nucleic acid, the six others were negative by WNV-specific RT-qPCR, but positive by USUV-specific RT-qPCR.

The authors concluded that although USUV is a potential human pathogen, there are no specific regulations on screening blood donations for this virus. According to the general rules, only clinically healthy people are allowed to donate blood. However, the USUV-positive blood donors did not show any symptoms before and after donation. They propose that extension of flavivirus screening of blood donations might be taken into consideration by USUV-endemic European countries.

In order to raise awareness and allow timely actions, they intentionally wrote this paper at this point in time when the WNV and USUV transmission seasons are still ongoing, which, depending on weather conditions, may last in central Europe until the end of October. The study was published in the October 2017 edition of the journal Eurosurveillance.

Related Links:
University of Veterinary Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.